This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Yasuhisa Sakurai: Innovator in Drug Preparation Technology
Introduction
Yasuhisa Sakurai is a notable inventor from Japan, recognized for his contributions to the field of drug preparation technology. His innovative work focuses on the development of water-soluble high molecular polymerized drugs, which have significant implications for medical treatments.
Latest Patents
Sakurai's most prominent invention is a water-soluble high molecular polymerized drug preparation. This invention comprises a water-soluble block copolymer that includes a hydrophilic segment and a hydrophobic pharmacological-functioning segment to which a drug is bonded. The hydrophilic segment can include materials such as polyethylene glycol, polysaccharides, and polyacrylamide. The hydrophobic segment, which is attached to the drug, may consist of polyaspartic acid, polyglutamic acid, polylysine, or their derivatives. The drugs that can be attached to the hydrophobic segment include anti-cancer drugs, drugs for central and peripheral nerves, and drugs for circulatory organs.
Career Highlights
Throughout his career, Yasuhisa Sakurai has made significant strides in the pharmaceutical field. His innovative approaches to drug formulation have paved the way for advancements in medical treatments. Despite having no registered patents, his work remains influential in the development of new therapeutic strategies.
Collaborations
Sakurai has collaborated with notable figures in the industry, including Teruo Okano and Kazunori Kataoka. These partnerships have contributed to the advancement of research and development in drug preparation technologies.
Conclusion
Yasuhisa Sakurai's contributions to the field of drug preparation technology highlight his innovative spirit and dedication to improving medical treatments. His work continues to inspire future advancements in pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile